Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

5.49
+0.920020.13%
Post-market: 5.570.0800+1.46%19:59 EDT
Volume:60.32M
Turnover:318.68M
Market Cap:2.23B
PE:-3.02
High:5.52
Open:4.72
Low:4.71
Close:4.57
Loading ...
May 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 16, 2024

Major Issues Report

Form 8-K - Current report
Apr 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2024

Major Issues Report

Form 8-K - Current report